Delivery Order SPE2DB20D1110-SPE2DB25FK41D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,878.18 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This non-set-aside, competitively awarded contract reflects firm fixed pricing and was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $2,977.70 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a $1,784.23 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a generic medication commonly used in diabetes management. This firm fixed price, competitively awarded delivery order was finalized on August 11, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.96 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a ceiling value of $1,260.82 and an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,739.94 for 100 tablets of Glimepiride 4 mg on August 25, 2025, with completion anticipated by August 26, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Glimepiride is an oral antidiabetic medication commonly utilized in military and veteran...
- The Defense Logistics Agency awarded a $2,363.53 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 2 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $6,453.34. The delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a firm fixed price ceiling value of $1,037.97. The contract, classified as a delivery order with no set-aside designation, was competitively awarded on August 21, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Glimepiride 4 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,126.05 under firm fixed price terms, with an ultimate completion date of September 9, 2025. The delivery order was issued on September 8, 2025, and will be performed at...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK41DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,968.93 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills diverse pharmaceutical supply requirements across the Defense Health Agency, U.S. Coast Guard, and related government healthcare systems. The company's portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities spanning multiple therapeutic domains. This particular delivery order for the diabetes medication Glimepiride exemplifies the routine pharmaceutical procurement activities executed through the broader SPE2DX vehicle, demonstrating the company's role in sustaining military medical supply chains with both specialty and routine pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/12/25 |